SYMBICORT indications

SYMBICORT indications

SYMBICORT is indicated for the treatment of asthma in patients 12 years and older uncontrolled on an ICS or whose disease severity clearly warrants an ICS/LABA (also see Boxed WARNING).

SYMBICORT 160/4.5 is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

SYMBICORT is NOT indicated for the relief of acute bronchospasm and should not be initiated in patients during rapidly deteriorating or potentially life-threatening episodes of asthma or COPD.

SYMBICORT 160/4.5 FOR COPD

View clinical data about the safety and efficacy of SYMBICORT.

SYMBICORT FOR ASTHMA

View clinical data about the safety and efficacy of SYMBICORT.

*Subject to eligibility rules; restrictions apply.